(Total Views: 569)
Posted On: 10/30/2020 7:39:13 AM
Post# of 154477
Call the dogs back. Easy on him, he appears to have merely forgotten to put in the citation. It's from a Seeking Alpha article this morning.
By the way, it appears to be a favorable analysis of CytoDyn within an article about a couple biotechs.
The portion of the article on CytoDyn concludes, as follows:
Here's the citation: https://seekingalpha.com/article/4383011-rege...-biopharma
By the way, it appears to be a favorable analysis of CytoDyn within an article about a couple biotechs.
The portion of the article on CytoDyn concludes, as follows:
Quote:
Investment Thesis: While CytoDyn is deriving synergies by developing its lead candidate Leronlimab for different indications, its COVID-19 program is also expected to yield positive results.
Here's the citation: https://seekingalpha.com/article/4383011-rege...-biopharma
(1)
(0)
